This website uses cookies to store user session information. By using our website you consent to our terms of use. Read more
I agree
31.03.1969
6172543
ants.kask@regionaalhaigla.ee

Career

Institutions and positions
01.09.2017–...   
North Estonian Regional Hospital, Psychiatrist, Senior Physician, Head of Unit (1,00)
01.10.2013–31.08.2017   
North Estonian Regional Hospital, Head of Unit (0,50)
01.09.2013–31.08.2017   
North Estonian Regional Hospital, Resident Physician in Psychiatry (1,00)
01.01.2013–31.08.2013   
Wismar Psychiatric Hospital, General Physician (1,00)
2009–2012   
Merck Sharp & Dohme Llc, Baltic Medical Affairs Director/Chief Medical Officer (1,00)
2004–2008   
Merck Sharp & Dohme Llc, Baltic Medical Advisor (1,00)
2001–2003   
Merck Sharp & Dohme Llc, Product Manager (1,00)
01.01.2000–31.12.2001   
Douglas Hospital, McGill University, post-doctoral student
 
 
Education
2013–31.08.2017   
University of Tartu, Faculty of Medicine, Residency Program in Psychiatry
1994–1999   
University of Tartu, Faculty of Medicine, Department of Pharmacology, doctoral studies
1990–1994   
University of Tartu, Faculty of Medicine
1987–1990   
S.M. Kirov Military Medical Academy, Leningrad
 
 
R&D related managerial and administrative work
2020−...   
member of Ethical Committee for Human Studies, National Institute of Health Development
2019−...   
Board Member of Estonian Society of Psychiatrists
2013−...   
Estonian Society of Psychiatry, member
1994−...   
Estonian Society of Pharmacology, member

Qualifications

 
 
Honours & awards
1999, Ants Kask, European College of Neuropsychopharmacology Fellowship Award
 
 
Fields of research
ETIS CLASSIFICATION: 3. Health; 3.7. Clinical Medicine; CERCS CLASSIFICATION: B650 Psychiatry, clinical psychology, psychosomatics
 
 
Additional information
Basic Course on clinical trials, principles of their conduct and Good Clinical Practices. Oct 4-6th, 2019. North Estonia Medical Centre, Tallinn.

Publications

Category
Year
Publication
 
6.6.
2018
1.1.
2004
1.1.
2003
1.1.
2003
1.1.
2003
1.1.
2002
1.1.
2002
1.1.
2002
1.3.
2002
1.1.
2001
1.1.
2001
1.1.
2001
1.1.
2001
1.1.
2001
3.1.
2001
5.1.
2001
1.1.
2000
1.1.
2000
1.1.
2000
1.1.
2000
5.1.
2000
5.1.
2000
1.1.
1999
1.1.
1999
1.1.
1999
5.1.
1999
1.1.
1998
1.1.
1998
1.1.
1998
1.1.
1998
1.1.
1998
1.1.
1998
1.1.
1998
1.1.
1998
1.1.
1998
1.1.
1997
1.1.
1997
1.1.
1996
1.1.
1994
1.1.
1994

Industrial property

29.09.2021
31.03.1969
6172543
ants.kask@regionaalhaigla.ee

Teenistuskäik

Töökohad ja ametid
01.09.2017–...   
SA Põhja-Eesti Regionaalhaigla, psühhiaater, vanemarst-osakonnajuhataja (1,00)
01.10.2013–31.08.2017   
SA Põhja-Eesti Regionaalhaigla, osakonnajuhataja (0,50)
01.09.2013–31.08.2017   
SA Põhja-Eesti Regionaalhaigla, arst-resident (1,00)
01.01.2013–31.08.2013   
Wismari Haigla AS, üldarst (1,00)
2009–2012   
Merck Sharp & Dohme OÜ, Balti piirkonna meditsiiniala juht (1,00)
2004–2008   
Merck Sharp & Dohme OÜ, Balti meditsiiniala nõunik (1,00)
2001–2003   
Merck Sharp & Dohme OÜ, Tootejuht (1,00)
01.01.2000–31.12.2001   
McGilli Ülikool, järeldoktorant
 
 
Haridustee
2013–31.08.2017   
Tartu Ülikool, arstiteaduskond, residentuur psühhiaatria erialal
1994–1999   
Tartu Ülikool, arstiteaduskond, farmakoloogia instituut, doktorantuur
1990–1994   
Tartu Ülikool, arstiteaduskond, ravi eriala
1987–1990   
S.M. Kirovi-nimeline Sõjaväemeditsiini Akadeemia, Leningrad
 
 
Teadusorganisatsiooniline ja -administratiivne tegevus
2020−...   
Tervise Arengu Instituudi inimuuringute eetikakomitee liige
2019−...   
Eesti Psühhiaatrite Seltsi juhatuse liige
2013−...   
Eesti Psühhiaatrite Selts, liige
1994−...   
Eesti Farmakoloogia Selts, liige

Kvalifikatsioon

 
 
Teaduspreemiad ja tunnustused
1999, Ants Kask, Euroopa Neuropsühhofarmakoloogia Kolledzhi auhind
 
 
Teadustöö põhisuunad
ETIS KLASSIFIKAATOR: 3. Terviseuuringud; 3.7. Kliiniline meditsiin; CERCS KLASSIFIKAATOR: B650 Psühhiaatria, kliiniline psühholoogia, psühhosomaatika
 
 
Lisainfo
Ravimite kliiniliste uuringute, nende läbiviimise printsiipide ja heade kliiniliste tavade baaskoolitus 4-6. oktoober, 2019. SA PERH koolituskeskus, Tallinn.

Publikatsioonid

Klass
Aasta
Publikatsioon
 
6.6.
2018
1.1.
2004
1.1.
2003
1.1.
2003
1.1.
2003
1.1.
2002
1.1.
2002
1.1.
2002
1.3.
2002
1.1.
2001
1.1.
2001
1.1.
2001
1.1.
2001
1.1.
2001
3.1.
2001
5.1.
2001
1.1.
2000
1.1.
2000
1.1.
2000
1.1.
2000
5.1.
2000
5.1.
2000
1.1.
1999
1.1.
1999
1.1.
1999
5.1.
1999
1.1.
1998
1.1.
1998
1.1.
1998
1.1.
1998
1.1.
1998
1.1.
1998
1.1.
1998
1.1.
1998
1.1.
1998
1.1.
1997
1.1.
1997
1.1.
1996
1.1.
1994
1.1.
1994

Tööstusomand

29.09.2021

Search publication

  • {{item.Name}}
 until 
Beginning
Fuzzy
Precise
  • Found 40 results
PublicationAuthorsYearEdition titleClassificationFileR&D institutions
Perearstide ja peremeditsiini residentide kogemused alkoholisõltuvusega patsiendi ravimisel. Parik, I.; Kask, A., Suija, K.; Velgan, M. 2018Perearst6.6.University of Tartu, Faculty of Medicine, Institute of Family Medicine and Public Health
Increased behavioural activity of rats in forced swimming test after partial denervation of serotonergic system by parachloroamphetamine treatmentHaidkind, R.; Eller, M.; Kask, A.; Harro, M.; Rinken, A.; Oreland, L.; Harro, J.2004Neurochemistry International1.1.University of Tartu, Faculty of Physics and Chemistry, Institute of Organic and Bioorganic Chemistry;
University of Tartu, Faculty of Social Sciences and Education, Department of Psychology;
University of Tartu, Faculty of Medicine, Department of Public Health;
University of Tartu, Faculty of Medicine, Department of Pharmacology;
University of Tartu
Effects of partial locus coeruleus denervation and chronic mild stress on behaviour and monoamine neurochemistry in the ratHaidkind, R.; Eller, M.; Harro, M.; Kask, A.; Rinken, A.; Oreland, L.; Harro, J.2003European Neuropsychopharmacology1.1.University of Tartu;
University of Tartu, Faculty of Medicine, Department of Pharmacology;
University of Tartu, Faculty of Medicine, Department of Public Health;
University of Tartu, Faculty of Physics and Chemistry, Institute of Organic and Bioorganic Chemistry;
University of Tartu, Faculty of Social Sciences and Education, Department of Psychology
Novel selective melanocortin 4 receptor antagonist induces food intake after peripheral administrationSchioth, HB.; Kask, A.; Mutulis, F.; Muceniece, R.; Mutule, I.; Mutule, I.; Mandrika, I.; Wikberg, JES.2003Biochemical and Biophysical Research Communications1.1.University of Tartu;
University of Tartu, Faculty of Medicine, Department of Pharmacology
Transgenic rat model of Huntington's diseaseSchmitt, I.; Nguyen, HP.; Holzmann, C.; Schmidt, T.; Walther, T.; Bader, M.; Pabst, R.; Kobbe, P.; Krotova, J.; Stiller, D.; Kask, A.; Vaarmann, A.; Rathke-Hartlieb, S.; Schulz, JB.; Grasshoff, U.; Bauer, I.; Vieira-Saecker, AMM.; Paul, M.; Jones, L.; Linden, L.2003Human Molecular Genetics1.1.University of Tartu, Faculty of Medicine, Department of Pharmacology;
University of Tartu
Effects of melanocortin receptor ligands on ethanol intake and opioid peptide levels in alcohol-preferring AA ratsPloj, K.; Roman, E.; Kask, A.; Schioth, HB.; Wikberg, JES.; Nylander, I.2002Brain Research Bulletin1.1.University of Tartu, Faculty of Medicine, Department of Pharmacology;
University of Tartu
Novel and sensitive high-performance liquid chromatographic method based on electrochemical coulometric array detection for simultaneous determination of catecholamines, kynurenine and indole derivatives of tryptophanVaarmann, A.; Kask, A.; Maeorg, U.2002Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences1.1.University of Tartu, Faculty of Medicine, Department of Pharmacology;
University of Tartu;
University of Tartu, Faculty of Physics and Chemistry, Institute of Organic and Bioorganic Chemistry
The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide YKask, A.; Harro, J.; Redrobe, JP.; Dumont, Y.; Quirion, R.2002Neuroscience and Biobehavioral Reviews1.1.University of Tartu;
University of Tartu, Faculty of Medicine, Department of Pharmacology;
University of Tartu, Faculty of Social Sciences and Education, Department of Psychology
Kehalisest pingutusest tingitud astma diagnoosimine ja ravivõimalusedVoor, T.; Kask, A.; Julge, K.2002Eesti Arst1.3.University of Tartu;
Tartu University Hospital, Children's Clinic of Tartu University Hospital;
University of Tartu, Faculty of Medicine, Department of Pharmacology
Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: effects on behavior and monoamine neurochemistryHarro, J.; Tonissaar, M.; Eller, M.; Kask, A.; Oreland, L.2001Brain Research1.1.University of Tartu;
University of Tartu, Faculty of Medicine, Department of Pharmacology;
University of Tartu, Faculty of Social Sciences and Education, Department of Psychology
Cocaine and amphetamine-regulated transcript peptide (CART(62-76))-induced changes in regional monoamine levels in rat brainVaarmann, A.; Kask, A.2001Neuropeptides1.1.University of Tartu, Faculty of Medicine, Department of Pharmacology;
University of Tartu
Factors influencing behavior of group-housed male rats in the social interaction test Focus on cohort removalKask, A.; Nguyen, HP.; Pabst, R.; von Horsten, S.2001Physiology & Behavior1.1.University of Tartu, Faculty of Medicine, Department of Pharmacology;
University of Tartu
Neuropeptide YY1 receptor-mediated anxiolysis in the dodsocaudal lateral septum: Functional antagonism of corticotropin-releasing hormone-induced anxietyKask, A.; Nguyen, HP.; Pabst, R.; Von Horsten, S.2001Neuroscience1.1.University of Tartu, Faculty of Medicine, Department of Pharmacology;
University of Tartu
Neuropeptide YY5 receptor antagonist CGP71683A: the effects on food intake and anxiety-related behavior in the ratKask, A.; Vasar, E.; Heidmets, LT.; Allikmets, L.; Wikberg, JES.2001European Journal of Pharmacology1.1.University of Tartu;
University of Tartu, Faculty of Medicine, Department of Physiology;
University of Tartu, Faculty of Medicine, Department of Pharmacology
Melanocortin receptors in the regulation of food intakeKask, Ants; Skottner, Anna2001Perspectives in Comparative Endocrinology. Medimond International Proceedings.3.1.University of Tartu
Slowly progressive cerebral dysfunction with selective striatal neuronal inclusions in a rat model transgenic for the Huntington disease mutation.Riess, O.; Schmitt, I.; Nguyen, HP.; Holzmann, C.; Schmidt, T.; Walther, T.; Bader, M.; Pabst, R.; Kobbe, P.; Stiller, D.; Kask, A.; Vaarmann, A.; Rathke-Hartlieb, S.; Schulz, JB.; Grasshoff, U.; Bauer, I.; Paul, M.; Landwehrmeyer, B.; Li, XJ.; von Hoersten, S.2001The American Journal of Human Genetics5.1.University of Tartu;
University of Tartu, Faculty of Medicine, Department of Pharmacology
Differential effects of beta-carbolines and antidepressants on rat exploratory activity in the elevated zero-mazePahkla, R.; Kask, A.; Rago, L.2000Pharmacology Biochemistry and Behavior1.1.University of Tartu;
University of Tartu, Faculty of Medicine, Department of Pharmacology
Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide YY1 receptor antagonist BIBO 3304Kask, A.; Harro, J.2000Neuropharmacology1.1.University of Tartu, Faculty of Medicine, Department of Pharmacology;
University of Tartu;
University of Tartu, Faculty of Social Sciences and Education, Department of Psychology
Neuropeptide Y attenuates the effect of locus coeruleus denervation by DSP-4 treatment on social behaviour in the ratKask, A.; Eller, M.; Oreland, L.; Harro, J.2000Neuropeptides1.1.University of Tartu, Faculty of Medicine, Department of Pharmacology;
University of Tartu;
University of Tartu, Faculty of Social Sciences and Education, Department of Psychology
Orexigenic effect of the melanocortin MC4 receptor antagonist HS014 is inhibited only partially by neuropeptide YY1 receptor selective antagonistsKask, A.; Schioth, HB.; Harro, J.; Wikberg, JES.; Rago, L.2000Canadian Journal of Physiology and Pharmacology1.1.University of Tartu, Faculty of Social Sciences and Education, Department of Psychology;
University of Tartu;
University of Tartu, Faculty of Medicine, Department of Pharmacology
Comparison of chronic mild stress and chronic variable stress regime for modelling depression in ratsTonissaar, M.; Harro, JH.; Kask, AR.2000International Journal of Psychology5.1.University of Tartu;
University of Tartu, Faculty of Medicine, Department of Pharmacology;
University of Tartu, Faculty of Social Sciences and Education, Department of Psychology
Neuropeptide Y as a candidate peptide for coordinating seeking behaviourHarro, J.; Kask, A.2000International Journal of Psychology5.1.University of Tartu;
University of Tartu, Faculty of Medicine, Department of Pharmacology;
University of Tartu, Faculty of Social Sciences and Education, Department of Psychology
Dose-dependent effects of noradrenergic denervation by DSP-4 treatment on forced swimming and beta-adrenoceptor binding in the ratHarro, J.; Pahkla, R. ; Modiri, AR.; Harro, M.; Kask, A.; Oreland, L.1999Journal of Neural Transmission1.1.University of Tartu, Faculty of Medicine, Department of Pharmacology;
University of Tartu, Faculty of Medicine, Department of Public Health;
University of Tartu;
University of Tartu, Faculty of Social Sciences and Education, Department of Psychology
Long-term administration of MC4 receptor antagonist HS014 causes hyperphagia and obesity in ratsKask, A.; Pahkla, R.; Irs, A.; Rago, L.; Wikberg, JES.; Schioth, HB.1999Neuroreport1.1.University of Tartu;
University of Tartu, Faculty of Medicine, Department of Pharmacology
Neuropeptide YY1 receptor antagonist BIBP3226 produces conditioned place aversion in ratsKask, A.; Kivastik, T.; Rago, L.; Harro, J.1999Progress in Neuro-Psychopharmacology & Biological Psychiatry1.1.University of Tartu, Faculty of Social Sciences and Education, Department of Psychology;
University of Tartu, Faculty of Medicine, Department of Pharmacology;
University of Tartu